SOCS1 (Suppressor of cytokine signaling 1; also JAB/SSI-1) is a cytokine-inducible intracellular protein that acts as a potent negative-feedback inhibitor of JAK-STAT signaling, with a particularly essential role in limiting type I and type II interferon (especially IFN-gamma) responses, as well as IL2, IL4, IL6 and LIF signaling. It has a modular architecture comprising an N-terminal kinase inhibitory region (KIR), an extended SH2 subdomain (ESS), a central SH2 domain, and a C-terminal SOCS box. SOCS1 docks through its SH2 domain onto phosphotyrosine in the activation loop of receptor- associated Janus kinases (JAK1, JAK2 and TYK2), while its KIR acts as a pseudosubstrate that occludes the kinase substrate-binding groove, thereby directly inhibiting JAK catalytic activity and downstream STAT phosphorylation. Through its SOCS box, SOCS1 recruits the Elongin BC complex and a Cullin (CUL2/CUL5)/RBX1 scaffold to form an ECS (Elongin BC-Cullin-SOCS box) E3 ubiquitin ligase in which SOCS1 serves as the substrate- recognition subunit, targeting bound proteins (such as JAK2, IRS proteins and NF-kB RelA) for polyubiquitination and proteasomal degradation. SOCS1 thereby contributes to the termination of cytokine signaling and to immune homeostasis; it acts as a tumor suppressor and its loss or haploinsufficiency causes interferon-driven autoinflammatory and autoimmune disease.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0046426 negative regulation of receptor signaling pathway via JAK-STAT | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetically inferred negative regulation of JAK-STAT signaling. This is the central, defining function of SOCS1, supported by the founding experimental papers and conserved across orthologs. Reason: Core SOCS1 function; consistent with experimental evidence (PMID:9202125, PMID:9202126) and conserved across the SOCS1 family. |
| GO:0005126 cytokine receptor binding | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Phylogenetically inferred cytokine receptor binding. SOCS1 docks onto activated cytokine receptor / JAK complexes via its SH2 domain (e.g. IFNGR1), so binding to receptor components is plausible, but the informative molecular function is its kinase binding/inhibition rather than receptor binding per se. Reason: Consistent with SH2-mediated docking onto receptor complexes, but secondary to the core kinase-inhibitor / ubiquitin-adaptor functions. |
| GO:0019221 cytokine-mediated signaling pathway | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: SOCS1 acts within cytokine-mediated signaling pathways as a negative-feedback regulator. Accurate but general; the more specific term is negative regulation of JAK-STAT signaling. Reason: Correct but high-level; the negative-regulation JAK-STAT term captures the core role more precisely. |
| GO:0005634 nucleus | IEA GO_REF:0000044 | KEEP AS NON CORE | Summary: Electronic subcellular-location annotation. SOCS1 is detected in the nucleus and has reported nuclear activities (e.g. targeting nuclear RelA/p53), but its primary site of action is the cytoplasm. Reason: Supported by UniProt subcellular location (PubMed:16410555); non-core relative to cytoplasmic JAK regulation. |
| GO:0031410 cytoplasmic vesicle | IEA GO_REF:0000044 | KEEP AS NON CORE | Summary: Electronic location annotation reflecting detection in perinuclear cytoplasmic vesicles upon interaction with FGFR3. Condition-specific localization. Reason: Supported by UniProt (PubMed:16410555) but condition-specific and non-core. |
| GO:0032502 developmental process | IEA GO_REF:0000117 | MARK AS OVER ANNOTATED | Summary: Very general ARBA-derived developmental-process annotation. Uninformative for SOCS1's specific function. Reason: Root-level/very general term with no specific support; over-annotation. |
| GO:0035556 intracellular signal transduction | IEA GO_REF:0000002 | KEEP AS NON CORE | Summary: InterPro-derived general signal-transduction annotation. SOCS1 indeed acts in intracellular signaling, but as a negative regulator; the term is high-level. Reason: Correct but very general; superseded by the specific JAK-STAT negative-regulation term. |
| GO:0005515 protein binding | IPI PMID:16273093 A quantitative protein interaction network for the ErbB rece... | MARK AS OVER ANNOTATED | Summary: Generic protein-binding annotation from an ErbB SH2/PTB protein-microarray network (interaction with ERBB2/P04626). Uninformative term per curation guidelines. Reason: 'protein binding' is uninformative; high-throughput interaction not central to SOCS1 function. |
| GO:0005515 protein binding | IPI PMID:16643902 The E3 ubiquitin ligase HOIL-1 induces the polyubiquitinatio... | KEEP AS NON CORE | Summary: Generic protein-binding annotation (interaction with ELOC/Q15369). The SOCS1-Elongin C interaction is biologically real and underlies the SOCS-box E3 adaptor function, but the GO term itself is uninformative. Reason: Interaction is meaningful (Elongin C / SOCS-box) but the generic term does not convey the adaptor function captured in core_functions. |
| GO:0005515 protein binding | IPI PMID:17183367 COMMD1 promotes the ubiquitination of NF-kappaB subunits thr... | KEEP AS NON CORE | Summary: Generic protein-binding annotation backing the ECS(SOCS1) complex with RelA/Elongin C/COMMD1. Biologically central to the ubiquitin-ligase adaptor role, but recorded under the uninformative 'protein binding' term. Reason: Underlying interaction supports the E3 substrate-adaptor core function; term itself is generic. |
| GO:0005515 protein binding | IPI PMID:18172216 SOCS1 is an inducible host factor during HIV-1 infection and... | KEEP AS NON CORE | Summary: Generic protein-binding annotation for the direct SOCS1-HIV-1 Gag interaction (via SOCS1 SH2). Host-pathogen interaction, not core cellular physiology. Reason: Real direct interaction but virus-related and peripheral; generic term. |
| GO:0005515 protein binding | IPI PMID:31980649 Extensive rewiring of the EGFR network in colorectal cancer ... | MARK AS OVER ANNOTATED | Summary: Generic protein-binding annotation from a large-scale KRAS/EGFR-network AP-MS study (interaction with ELOC/Q15369). Uninformative term, high-throughput context. Reason: 'protein binding' is uninformative; high-throughput interaction. |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | MARK AS OVER ANNOTATED | Summary: Generic protein-binding annotation from the HuRI binary interactome (interaction with SH3GL1/Q99961). Uninformative term, context-free high-throughput screen. Reason: 'protein binding' is uninformative; high-throughput interactome. |
| GO:0005515 protein binding | IPI PMID:35512704 Systematic discovery of mutation-directed neo-protein-protei... | MARK AS OVER ANNOTATED | Summary: Generic protein-binding annotation from a cancer neoPPI screen (interaction with SMAD4/Q13485). Uninformative term. Reason: 'protein binding' is uninformative; high-throughput screen. |
| GO:0019210 kinase inhibitor activity | IEA GO_REF:0000107 | MODIFY | Summary: Kinase inhibitor activity transferred from the mouse ortholog. Correct in essence; the more specific and experimentally supported term is protein kinase inhibitor activity (GO:0004860). Reason: Generalize-to-specific: SOCS1 specifically inhibits protein (tyrosine) kinases (JAKs); replace with protein kinase inhibitor activity. Proposed replacements: protein kinase inhibitor activity |
| GO:0043372 positive regulation of CD4-positive, alpha-beta T cell differentiation | IEA GO_REF:0000107 | KEEP AS NON CORE | Summary: T-cell differentiation role transferred electronically from the mouse ortholog (O35716). Consistent with SOCS1's role in T-cell homeostasis but not a core molecular function. Reason: Plausible from mouse ortholog; downstream immunophysiology, non-core. |
| GO:0043377 negative regulation of CD8-positive, alpha-beta T cell differentiation | IEA GO_REF:0000107 | KEEP AS NON CORE | Summary: Electronic transfer from the mouse ortholog. Consistent with SOCS1's T-cell regulatory role; non-core. Reason: Plausible from mouse ortholog; downstream immunophysiology, non-core. |
| GO:0016567 protein ubiquitination | IEA GO_REF:0000041 | ACCEPT | Summary: UniPathway-derived protein-ubiquitination annotation. Reflects SOCS1's SOCS-box E3 ubiquitin ligase substrate-recognition role, which targets bound substrates for ubiquitination and proteasomal degradation. Reason: Core process consistent with the ECS(SOCS1) E3 ligase adaptor function (PMID:17183367). |
| GO:0005654 nucleoplasm | IDA GO_REF:0000052 | KEEP AS NON CORE | Summary: Immunofluorescence-based (HPA) nucleoplasm localization. SOCS1 has documented nuclear pools and nuclear substrates; primary functional site remains cytoplasmic. Reason: Experimentally observed location; non-core relative to cytoplasmic JAK regulation. |
| GO:0030225 macrophage differentiation | IMP PMID:32634427 Downregulation of microRNA-155-5p prevents immune thrombocyt... | KEEP AS NON CORE | Summary: SOCS1 (a miR-155-5p target) promotes macrophage M2 polarization via the PD1/PDL1 pathway in an immune thrombocytopenia model. Reflects a downstream contextual role in macrophage biology. Reason: Experimental (IMP) but downstream/contextual; not a core molecular function. Defer to curator on the precise differentiation term. |
| GO:0005515 protein binding | IPI PMID:23401859 DCNL1 functions as a substrate sensor and activator of culli... | MARK AS OVER ANNOTATED | Summary: Generic protein-binding annotation from a DCNL1/CUL2-neddylation study (with DCUN1D1/O14508). Consistent with SOCS1's CRL2/CRL5 substrate-receptor context but recorded under the uninformative 'protein binding' term. Reason: 'protein binding' is uninformative; interaction is contextual to CRL machinery. |
| GO:0043372 positive regulation of CD4-positive, alpha-beta T cell differentiation | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Sequence-similarity transfer (from mouse O35716) of the CD4 T-cell differentiation role; duplicates the IEA annotation above. Non-core. Reason: By-similarity immunophysiology; non-core. |
| GO:0043377 negative regulation of CD8-positive, alpha-beta T cell differentiation | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Sequence-similarity transfer of the CD8 T-cell differentiation role; duplicates the IEA annotation. Non-core. Reason: By-similarity immunophysiology; non-core. |
| GO:0045591 positive regulation of regulatory T cell differentiation | IMP PMID:22387553 Downregulation of inflammatory microRNAs by Ig-like transcri... | UNDECIDED | Summary: Annotation from a study of ILT3-induced CD8+ T suppressor cell differentiation in which SOCS1 is a direct miR-155 target. The cached abstract does not clearly establish a direct SOCS1 role in regulatory T cell differentiation; the supporting detail is in full text not available here. Reason: Cannot verify the specific Treg-differentiation claim from the cached abstract; per guidelines use UNDECIDED rather than overruling the experimental annotation. |
| GO:0046426 negative regulation of receptor signaling pathway via JAK-STAT | IMP PMID:25019494 MiR-221 accentuates IFN's anti-HCV effect by downregulating ... | ACCEPT | Summary: Experimental support: miR-221 downregulation of SOCS1/SOCS3 potentiates IFN's anti-HCV effect, with SOCS1/SOCS3 described as established inhibitors of the IFN/JAK/STAT pathway. Reinforces the core negative-regulation function. Reason: Core JAK-STAT negative-regulation function, experimentally supported. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-6785860 | ACCEPT | Summary: Cytosolic localization (Reactome). SOCS1 acts on receptor-associated JAKs in the cytoplasm; this is its primary functional compartment. Reason: Primary site of action; consistent across sources. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-877269 | ACCEPT | Summary: Cytosolic localization (Reactome), from the SOCS-1/SOCS-3 binding to p-JAK2 event. Consistent with the core cytoplasmic JAK-regulation role. Reason: Primary functional compartment. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-8983011 | ACCEPT | Summary: Cytosolic localization (Reactome). Redundant with other cytosol annotations. Reason: Consistent cytosolic localization. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-9705738 | ACCEPT | Summary: Cytosolic localization (Reactome), from the SOCS1/3 CSF3R ubiquitination event. Consistent with the SOCS-box E3 adaptor activity occurring in the cytoplasm. Reason: Consistent cytosolic localization. |
| GO:0005829 cytosol | TAS Reactome:R-NUL-1169195 | ACCEPT | Summary: Cytosolic localization (Reactome). Redundant cytosol annotation. Reason: Consistent cytosolic localization. |
| GO:0019210 kinase inhibitor activity | ISS GO_REF:0000024 | MODIFY | Summary: Sequence-similarity transfer of kinase inhibitor activity. As with the IEA version, the specific supported term is protein kinase inhibitor activity (GO:0004860). Reason: Generalize-to-specific: replace with protein kinase inhibitor activity. Proposed replacements: protein kinase inhibitor activity |
| GO:0019221 cytokine-mediated signaling pathway | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Sequence-similarity transfer placing SOCS1 in cytokine-mediated signaling. Correct but general; SOCS1's specific role is negative regulation of JAK-STAT signaling. Reason: Correct but high-level; superseded by the specific negative-regulation term. |
| GO:0046426 negative regulation of receptor signaling pathway via JAK-STAT | ISS GO_REF:0000024 | ACCEPT | Summary: Sequence-similarity transfer of the core JAK-STAT negative-regulation function. Fully consistent with experimental evidence. Reason: Core SOCS1 function, corroborated experimentally and by orthology. |
| GO:0046627 negative regulation of insulin receptor signaling pathway | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Sequence-similarity transfer (mouse O35716) of negative regulation of insulin receptor signaling. SOCS1 is reported to attenuate insulin/IGF signaling (e.g. via IRS targeting), but this is a secondary, context-specific role. Reason: Plausible secondary role; non-core relative to cytokine/JAK regulation. |
| GO:0005159 insulin-like growth factor receptor binding | IPI PMID:9727029 Interaction of human suppressor of cytokine signaling (SOCS)... | KEEP AS NON CORE | Summary: IPI annotation supported by the explicit statement that hSOCS-1 interacts strongly with IGF-IR in the two-hybrid assay. Real SH2-mediated interaction, but peripheral to SOCS1's canonical cytokine-signaling role. Reason: Experimentally supported interaction (PMID:9727029) but a secondary, receptor-specific binding rather than a core function. |
| GO:0019901 protein kinase binding | IPI PMID:9727029 Interaction of human suppressor of cytokine signaling (SOCS)... | ACCEPT | Summary: Protein kinase binding annotation (WITH JAK2/O60674). SOCS1 binding to activated JAKs through its SH2 domain is central to its mechanism; protein kinase binding is an informative, accurate molecular function. Reason: Captures SOCS1's mechanistically essential binding to JAK kinases; core function. |
| GO:0046426 negative regulation of receptor signaling pathway via JAK-STAT | NAS PMID:9727029 Interaction of human suppressor of cytokine signaling (SOCS)... | ACCEPT | Summary: Non-traceable author statement of the core JAK-STAT negative-regulation function. Consistent with the wealth of experimental evidence even though the assertion here is by analogy in a SOCS-2-focused paper. Reason: Core function; abundantly supported elsewhere (PMID:9202125, PMID:9202126). |
| GO:0004860 protein kinase inhibitor activity | TAS PMID:9202125 A family of cytokine-inducible inhibitors of signalling. | ACCEPT | Summary: Traceable-author-statement annotation of protein kinase inhibitor activity from the founding SOCS family paper. This is the precise, experimentally grounded core molecular function of SOCS1 (direct inhibition of JAK catalytic activity). Reason: Core molecular function; directly supported by PMID:9202125 and PMID:9202126. |
| GO:0005737 cytoplasm | TAS PMID:9202126 A new protein containing an SH2 domain that inhibits JAK kin... | ACCEPT | Summary: Cytoplasmic localization from the founding JAB paper. SOCS1 acts on cytoplasmic receptor-associated JAKs; cytoplasm/cytosol is its principal compartment. Reason: Primary functional compartment; consistent with cytosol annotations. |
Loading supporting content…
Download this section (compressed HTML)Q: What is the full repertoire of physiological SOCS1 ubiquitination substrates beyond JAKs (e.g. NF-kB RelA, IRS1/2, FAK), and which are degraded versus non-degradatively regulated in primary immune cells?
Q: How is the balance between SOCS1's direct kinase-inhibitory (KIR/SH2) activity and its SOCS-box E3-adaptor activity tuned in different cytokine contexts?
Experiment: Separation-of-function mutants (KIR-dead vs SOCS-box-dead vs SH2-dead) expressed in SOCS1-null cells, with quantitative phospho-JAK/STAT and substrate-degradation readouts across IFN-gamma, IL2, IL4 and IL6 stimulation, to dissect the relative contributions of kinase inhibition and ubiquitin-mediated degradation.
Experiment: Proximity-labeling (BioID/TurboID) and ubiquitin-remnant proteomics in cytokine- stimulated primary T cells/macrophages to define the endogenous SOCS1 interactome and its degradation targets in a physiological setting.
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)